Skip to Content

Tag: Portal Diabetes


Also Noted

Portal Diabetes achieves Breakthrough designation from FDA for implantable insulin pump

February 17, 2026HME News Staff

WESTFIELD, Ind.  – Portal Diabetes has received Breakthrough Device Designation by the Food and Drug Administration (FDA) for its implantable insulin pump system called Portal Pump, and the start of a Phase 1 study on its proprietary temperature-stable insulin, Portal Insulin. The company aims to deliver a functional cure to type 1 diabetes – an implantable insulin pump leveraging the physiologic delivery of insulin to the abdomen, modern continuous glucose monitoring...

Insulin pump, Portal Diabetes, Type 1 Diabetes


Read Full Articlered right arrow icon